Applied Filters
UK regulators no longer exempt from paying successful parties' costs
The UK Supreme Court has ruled that regulators such as the Competition and Markets Authority should be required to pay the costs of a party successfully appealing against one of their infringement decisions.
English High Court denies Jazz units’ jurisdictional challenge
Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.
GSK to buy Sierra Oncology for $1.9bn
GlaxoSmithKline has agreed to acquire California-based biopharma company Sierra Oncology for $1.9 billion, in a move that bolsters the UK company’s cancer business.
Pharma patent filings rise at EPO amid pandemic
Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office.
EC reveals plans for unitary SPC, compulsory licences
The European Commission will unveil plans to make supplementary protection certificates more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.
English High Court denies Mylan a stay in Neurim litigation
Mylan has failed to secure a stay in litigation centring on a melatonin-based insomnia patent at the English High Court.
CMA fines drugmakers £260m for 10,000% price hike
The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.
UK Supreme Court shoots down NHS £220m drug patent suit
The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.
English High Court strikes out bad faith ‘Revolax’ TM
A Warrington-based distributor of aesthetic and cosmetic products has lost its UK trademark for a dermal filler brand after the English High Court found it to have registered the brand in bad faith.
EU backs compulsory licensing for COVID vaccines
The European Union has submitted a new proposal to the World Trade Organisation, which backs compulsory licensing agreements for COVID-19 vaccines when negotiations fail.
